About Titeris
We're a new UK supplier of research-use-only peptides, launched in 2026. Our whole approach is built around one idea: publish real, batch-matched documentation, say plainly what we don't yet do, and let that stand in for hype we're not interested in writing.
What we do
We sell a focused catalogue of research-use-only peptides, including BPC-157, TB-500, GHK-Cu and a small number of others, sourced from a wholesale supplier and shipped to you directly from that supplier's stock. We are not a laboratory, and we've never described ourselves as one. What we publish against each listing is our supplier's own third-party batch documentation, credited by name to the lab that produced it, with a plain statement on the page where a specific batch doesn't currently have documentation attached.
We launched with eight compounds rather than the eighty-plus some competitors list on day one, and that was a deliberate choice. A long catalogue is easy to write. A long catalogue you can genuinely stand behind, batch by batch, is not, and we weren't willing to fake the second thing just to look bigger. We'll add to the range only as fast as documentation can keep up with it, not before.
Why documentation is the whole idea, not a feature of it
Titeris exists because of a specific, well-documented problem in this category: the person buying a research peptide is usually the one carrying all the risk, with almost no reliable way to check what they've actually received. UK forums where buyers discuss this market are full of threads asking whether a given vendor is legitimate, cross-checking a certificate's batch number against what actually shipped, or reporting that a "lab-tested" product turned out to contain far less of the stated compound than the label claimed. That's not a rare complaint from one unlucky buyer. It's close to the default experience this category has trained people to expect, and it's the reason "trust us" has stopped meaning much here.
Our purpose is one sentence, and we mean it plainly rather than as a slogan on a wall: put the proof in the hands of the person taking the risk, so nobody has to trust what they can't check for themselves. Everything else on this site, the batch-matched documentation, the plain statement when documentation is missing, the deliberately narrow catalogue, follows from that idea rather than from a marketing brief someone wrote after the fact.
You'll notice the site itself reflects the same idea. We didn't build it around product photography or lifestyle shots, because neither one proves anything about what's actually in a vial. Instead, the pages are built around the paperwork: certificate-style layouts, batch tables, plain language about what a chromatogram trace does and doesn't establish. It's a slower, less flattering way to design a website than a glossy product shot, and it's also the only version of "look how legitimate we are" a reader can actually check, rather than simply take our word for.
What that looks like in practice
We name the gap before you find it
If a batch lacks documentation, or a compound lacks human safety data, which for research peptides it usually does, the page says so directly instead of hoping nobody asks. A stated limit tells you more than a confident guess ever could.
One batch, one document set
We tie the paperwork we publish to a specific batch code, never one certificate reused across an entire product line. Where that link doesn't exist yet for a given batch, the listing says that too, rather than let a similar-looking certificate imply a match it doesn't have.
Research framing, held to consistently
Every listing describes what a compound is and what testing shows, never what it will do for a person. That's the actual legal line under UK law, and it's also simply the honest way to write about a research material.
We stay small until the documentation catches up
We could list far more compounds today by relying on our supplier's word alone. We've chosen not to. Growing the catalogue only as fast as we can genuinely document it costs us some sales and some search visibility, and we've decided that trade is worth making rather than one worth skipping.
What we don't do
We don't sell to anyone under 18. We don't market or describe our products for human or veterinary use, and every listing carries the same research-use-only framing and disclaimer, in full, not buried in small print. We don't invent customer counts, testimonials, or "clinically proven" language, and we don't yet claim independent in-house testing, because it isn't true yet. See our documentation policy for the full detail.
We also don't claim to be the first, the biggest, or the cheapest, because none of those things happen to be true of us and we're not going to pretend they are. We don't run a loyalty scheme or a review carousel built to make a new, small supplier look busier than it is. And we don't hold up a purity percentage as proof of overall safety: it tells you about a compound's identity and concentration, nothing more, and we say that directly on the documentation policy page rather than let one number do more talking than it's entitled to.
Who we actually are
Titeris is a new business. We launched in 2026, and we're a small, UK-focused operation, not an established brand with decades of history or a large in-house team, and we're not going to invent ourselves one. We don't have named scientists on staff, an in-house laboratory, or a support floor running shifts around the clock. Enquiries go to a single inbox, read by the people who actually run the business, and we aim to reply within one UK working day rather than promise something faster we couldn't reliably keep.
Being new and small is honestly part of why this model works at all. A catalogue with hundreds of live batches would make genuine batch-matched documentation hard to maintain properly, and a badge would quietly start standing in for real paperwork. A short list, sold by a small team that reads every support email itself, is a size we can actually document honestly, batch by batch. We'd rather stay this size a while longer than grow past what we can stand behind, and if that means slower growth than a competitor willing to skip the paperwork, that's a trade we're making on purpose, not one we've been forced into.
We also won't pretend to a history we don't have. There's no founding story here involving a garage, a personal injury, or a scientist co-founder, because writing one would be exactly the kind of thing this page argues against. The honest version is plainer: we looked at a category where almost every seller claims to be trustworthy and almost none makes that claim checkable, and built the operating model described on this page as a direct answer to it. That's a smaller story than most "about us" pages tell. As far as we're concerned, it's also the only one worth telling if it isn't true.
Frequently asked
Is Titeris an established brand?
No, and we're not going to imply otherwise. We're a new, small UK supplier that launched in 2026. What we do claim, batch-matched documentation and a plain statement when that documentation doesn't yet exist, is true regardless of how long we've been trading, and we'd rather earn trust on that basis than borrow the look of a longer history we don't have.
Do you have your own laboratory?
No. We're not a laboratory and we've never presented ourselves as one. The documentation we publish today comes from our supplier's own third-party testing, credited to the lab that performed it. Read our documentation policy for exactly what that covers, and what it doesn't yet.
Will the catalogue grow?
Yes, but only as fast as documentation can genuinely keep up with it. We'd rather add a ninth compound once we can document it properly than list twenty more today on trust alone, which is exactly the shortcut this whole approach exists to avoid.
How do I get in touch?
Email support@titeris.co.uk. It goes straight to the people running the business, not a routing system, and we aim to reply within one UK working day. Full detail, including what to include for a faster answer, is on our contact page.
Do you have a founding story, like most "about us" pages?
Not one worth writing up, and we're not going to invent one. We're a new, small supplier built around a specific operating model, batch-matched documentation and honest limits, rather than a personal history. That model is the actual story here.